288 related articles for article (PubMed ID: 34772581)
21. Hearing Loss in Patients Who Received Cranial Radiation Therapy for Childhood Cancer.
Bass JK; Hua CH; Huang J; Onar-Thomas A; Ness KK; Jones S; White S; Bhagat SP; Chang KW; Merchant TE
J Clin Oncol; 2016 Apr; 34(11):1248-55. PubMed ID: 26811531
[TBL] [Abstract][Full Text] [Related]
22. Hearing Loss Risk in Pediatric Patients Treated with Cranial Irradiation and Cisplatin-Based Chemotherapy.
Cohen-Cutler S; Wong K; Mena V; Sianto K; Wright MA; Olch A; Orgel E
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1488-1495. PubMed ID: 33677052
[TBL] [Abstract][Full Text] [Related]
23. Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinoma.
Grau C; Møller K; Overgaard M; Overgaard J; Elbrønd O
Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):723-8. PubMed ID: 1869465
[TBL] [Abstract][Full Text] [Related]
24. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
Wei Z; Zhang Z; Luo J; Li N; Peng X
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162
[TBL] [Abstract][Full Text] [Related]
25. Inner ear deficits in irradiated nasopharyngeal carcinoma survivors.
Chi FH; Young YH
Laryngoscope; 2015 Nov; 125(11):2565-71. PubMed ID: 25945470
[TBL] [Abstract][Full Text] [Related]
26. Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Rasch CR; Tange RA; Balm AJ; Dreschler WA
Audiol Neurootol; 2006; 11(5):318-30. PubMed ID: 16983183
[TBL] [Abstract][Full Text] [Related]
27. Ototoxicity evaluation in medulloblastoma patients treated with involved field boost using intensity-modulated radiation therapy (IMRT): a retrospective review.
Vieira WA; Weltman E; Chen MJ; da Silva NS; Cappellano AM; Pereira LD; Gonçalves MI; Ferrigno R; Hanriot RM; Nadalin W; Odone Filho V; Petrilli AS
Radiat Oncol; 2014 Jul; 9():158. PubMed ID: 25041714
[TBL] [Abstract][Full Text] [Related]
28. Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective study.
Ho WK; Wei WI; Kwong DL; Sham JS; Tai PT; Yuen AP; Au DK
Head Neck; 1999 Sep; 21(6):547-53. PubMed ID: 10449671
[TBL] [Abstract][Full Text] [Related]
29. Evolution of postirradiated sudden deafness in nasopharyngeal carcinoma survivors during the past two decades.
Cho TY; Cheng PW; Young YH
Laryngoscope; 2016 Sep; 126(9):2016-21. PubMed ID: 26864918
[TBL] [Abstract][Full Text] [Related]
30. [Ototoxicity in head and neck cancers after radiotherapy and chemoradiotherapy: From primary prevention to tertiary prevention].
Espenel S; Garcia MA; Guy JB; Vallard A; Ben Mrad M; Langrand-Escure J; El Meddeb Hamrouni A; Trone JC; Xia Y; Rancoule C; Magné N
Cancer Radiother; 2017 Feb; 21(1):77-83. PubMed ID: 28189351
[TBL] [Abstract][Full Text] [Related]
31. Irradiated ears in nasopharyngeal carcinoma survivors: A review.
Young YH
Laryngoscope; 2019 Mar; 129(3):637-642. PubMed ID: 30194730
[TBL] [Abstract][Full Text] [Related]
32. Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical Trial.
Tang QN; Liu LT; Qi B; Guo SS; Luo DH; Sun R; Sun XS; Chen DP; Guo L; Mo HY; Wang P; Liu SL; Liang YJ; Li XY; Yang ZC; Chen QY; Mai HQ; Tang LQ
JAMA Netw Open; 2021 Dec; 4(12):e2138470. PubMed ID: 34928359
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of pediatric sensorineural hearing loss with magnetic resonance imaging.
McClay JE; Booth TN; Parry DA; Johnson R; Roland P
Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):945-52. PubMed ID: 18794439
[TBL] [Abstract][Full Text] [Related]
34. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
[TBL] [Abstract][Full Text] [Related]
35. Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial.
Li WF; Chen NY; Zhang N; Hu GQ; Xie FY; Sun Y; Chen XZ; Li JG; Zhu XD; Hu CS; Xu XY; Chen YY; Hu WH; Guo L; Mo HY; Chen L; Mao YP; Sun R; Ai P; Liang SB; Long GX; Zheng BM; Feng XL; Gong XC; Li L; Shen CY; Xu JY; Guo Y; Chen YM; Zhang F; Lin L; Tang LL; Liu MZ; Ma J; Sun Y
Int J Cancer; 2019 Jul; 145(1):295-305. PubMed ID: 30613964
[TBL] [Abstract][Full Text] [Related]
36. Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy.
Theunissen EA; Zuur CL; Józwiak K; Lopez-Yurda M; Hauptmann M; Rasch CR; van der Baan S; de Boer JP; Dreschler WA; Balm AJ
JAMA Otolaryngol Head Neck Surg; 2015 Sep; 141(9):810-5. PubMed ID: 26291150
[TBL] [Abstract][Full Text] [Related]
37. Phase II trial of neoadjuvant docetaxel and cisplatin followed by intensity-modulated radiotherapy with concurrent cisplatin in locally advanced nasopharyngeal carcinoma.
Zhong YH; Dai J; Wang XY; Xie CH; Chen G; Zeng L; Zhou YF
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1577-83. PubMed ID: 23549883
[TBL] [Abstract][Full Text] [Related]
38. Long-Term Progression of Sensorineural Hearing Loss and Tinnitus after Combined Intensity-Modulated Radiation Therapy and Cisplatin-Based Chemotherapy for Nasopharyngeal Carcinoma: A Case Report.
Lee MS; Penumala S; Sweet S; De Luca RR; Stearnes AE; Akgun Y
Case Rep Oncol; 2017; 10(2):743-751. PubMed ID: 28878660
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
Kong L; Zhang YW; Hu CS; Guo Y
Chin J Cancer; 2010 May; 29(5):551-5. PubMed ID: 20426907
[TBL] [Abstract][Full Text] [Related]
40. Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation.
Honoré HB; Bentzen SM; Møller K; Grau C
Radiother Oncol; 2002 Oct; 65(1):9-16. PubMed ID: 12413669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
